# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-038044
Filing Date
2025-03-12
Accepted
2025-03-12 16:55:31
Documents
88
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | scyx-20241231.htm iXBRL | 10-K | 3041557
2 | EX-19.1 | scyx-ex19_1.htm | EX-19.1 | 57730
3 | EX-23.1 | scyx-ex23_1.htm | EX-23.1 | 3997
4 | EX-31.1 | scyx-ex31_1.htm | EX-31.1 | 14784
5 | EX-31.2 | scyx-ex31_2.htm | EX-31.2 | 14765
6 | EX-32.1 | scyx-ex32_1.htm | EX-32.1 | 12520
| Complete submission text file | 0000950170-25-038044.txt |  | 13416451

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | scyx-20241231.xsd | EX-101.SCH | 1785047
90 | EXTRACTED XBRL INSTANCE DOCUMENT | scyx-20241231_htm.xml | XML | 2654107

Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36365 | Film No.: 25732446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)